Valuation: DBV Technologies

Market Cap 563M 634M 526M 479M 904M 60.96B 912M 6.36B 2.47B 31.16B 2.38B 2.33B 100B P/E 2026 *
-4.33x
P/E 2027 * -13.3x
Enterprise Value 488M 549M 455M 415M 783M 52.8B 790M 5.51B 2.14B 26.99B 2.06B 2.02B 86.62B EV / Sales 2026 *
179x
EV / Sales 2027 * 7.16x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 66 29/11/2018
Director of Finance/CFO 56 06/11/2023
Chief Operating Officer - 01/12/2023
Director TitleAgeSince
Director/Board Member 51 21/10/2015
Director/Board Member 63 21/06/2016
Director/Board Member 60 15/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 634M
-0.61%-3.43%+39.40%+112.31% 1,019B
-1.02%-5.60%+37.67%+65.02% 617B
+1.11%-0.58%+11.10%+77.28% 464B
+0.34%-3.01%+61.21%+40.71% 356B
-0.95%-4.05%+21.60%+39.37% 333B
-1.46%-2.89%+11.84%+24.60% 267B
-1.35%-5.43%-4.69%+8.40% 244B
-1.04%-2.79%+35.52%+51.34% 218B
-1.87%-4.10%+30.92%+95.33% 179B
Average -0.21%-3.39%+27.17%+57.15% 410.8B
Weighted average by Cap. +0.42%-3.33%+30.52%+68.96%

Financials

2026 *2027 *
Net sales 2.72M 3.06M 2.54M 2.31M 4.36M 294M 4.4M 30.71M 11.9M 150M 11.49M 11.24M 483M 62.06M 69.85M 57.92M 52.79M 99.57M 6.71B 100M 701M 272M 3.43B 262M 257M 11.02B
Net income -174M -196M -163M -148M -280M -18.85B -282M -1.97B -763M -9.64B -736M -720M -30.93B -126M -142M -118M -107M -202M -13.65B -204M -1.42B -552M -6.98B -533M -521M -22.39B
Net Debt -75.46M -84.93M -70.43M -64.19M -121M -8.16B -122M -852M -330M -4.17B -319M -312M -13.4B -119M -134M -111M -101M -191M -12.88B -193M -1.34B -521M -6.59B -503M -492M -21.14B
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-